Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep;34(3):713-718.
doi: 10.1007/s00062-024-01414-2. Epub 2024 Apr 30.

Endovascular Thrombectomy for Large Ischemic Strokes with ASPECTS 0-2: a Meta-analysis of Randomized Controlled Trials

Laurens Winkelmeier  1 , Máté Maros  2   3 , Fabian Flottmann  2 , Christian Heitkamp  2 , Gerhard Schön  4 , Götz Thomalla  5 , Jens Fiehler  2 , Uta Hanning  2
Affiliations
Meta-Analysis

Endovascular Thrombectomy for Large Ischemic Strokes with ASPECTS 0-2: a Meta-analysis of Randomized Controlled Trials

Laurens Winkelmeier et al. Clin Neuroradiol. 2024 Sep.

Abstract

Purpose: Randomized controlled trials (RCTs) demonstrated a treatment effect of endovascular thrombectomy in acute ischemic stroke with large infarct, commonly defined as an Alberta Stroke Program Early CT Score (ASPECTS) of 3-5. However, data on endovascular thrombectomy in patients with very low ASPECTS of 0-2 remain scarce.

Methods: We conducted a systematic review and meta-analysis of RCTs comparing endovascular thrombectomy versus medical treatment alone in acute ischemic anterior circulation stroke with very large infarct, defined as ASPECTS of 0-2. The primary outcome was the shift toward better functional outcomes on the 90-day modified Rankin Scale (mRS). Random effects meta-analysis was performed using the generic inverse variance method.

Results: Literature research identified four RCTs which evaluated the treatment effect of endovascular thrombectomy for large infarcts and provided a subgroup analysis of the mRS shift in patients with ASPECTS of 0-2. The pooled analysis showed a significant shift toward better 90-day mRS scores in favor of endovascular thrombectomy (pooled odds ratio, 1.62, 95% confidence interval, 1.29-2.04, P < 0.001).

Conclusion: This meta-analysis suggests a treatment effect of endovascular thrombectomy in specific patients with very low ASPECTS of 0-2, challenging the use of ASPECTS for treatment selection in acute ischemic stroke due to large vessel occlusion. An individual patient meta-analysis of RCTs would strengthen evidence in the treatment of patients with ASPECTS of 0-2.

Keywords: Cerebral infarction; Infarction; Ischemic stroke; Stroke; Thrombectomy.

PubMed Disclaimer

Conflict of interest statement

L. Winkelmeier, C. Heitkamp, G. Schön declare that they have no competing interests. M. Maros, F. Flottmann: Personal fees from Eppdata. G. Thomalla: Personal fees from Acandis, Alexion, Amarin, Bayer, Boehringer Ingelheim, Bristol Myers Squibb/Pfizer, Daiichi Sankyo, Portola, and Stryker. J. Fiehler: Personal fees from Acandis, Cerenovus, Medtronic, MicroVention, Medtronic, Penumbra, Phenox, Stryker, Tonbride, and Roche; stocks or stock options from Tegus Medical, Eppdata, and Vastrax. U. Hanning: Personal fees from Eppdata and Stryker.

Figures

Fig. 1
Fig. 1
Flow diagram
Fig. 2
Fig. 2
Random-effects meta-analysis to investigate the 90-day mRS shift in patients with ASPECTS of 0–2 who received endovascular thrombectomy compared with medical management alone. a Forest plot displaying the meta-analysis of four RCTs. The pooled results suggested a significant treatment effect of EVT for patients with ASPECTS of 0–2 (pooled odds ratio, 1.62, 95% CI, 1.29–2.04, P < 0.001). b Same as (a) after exclusion of LASTE. The pooled analysis of trials using CT as primary imaging modality also favored EVT (pooled odds ratio, 1.47, 95% CI, 1.05–2.05, P = 0.02)
See this image and copyright information in PMC

References

    1. Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Takeuchi M, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022; 10.1056/NEJMoa2118191. 10.1056/NEJMoa2118191 - DOI - PubMed
    1. Sarraj A, Hassan AE, Abraham MG, Ortega-Gutierrez S, Kasner SE, Hussain MS, Chen M, Blackburn S, Sitton CW, Churilov L, et al. Trial of endovascular thrombectomy for large Ischemic strokes. N Engl J Med. 2023; 10.1056/NEJMoa2214403. 10.1056/NEJMoa2214403 - DOI - PubMed
    1. Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, Yuan G, Han H, Chen W, Wei M, et al. Trial of endovascular therapy for acute Ischemic stroke with large infarct. N Engl J Med. 2023; 10.1056/NEJMoa2213379. 10.1056/NEJMoa2213379 - DOI - PubMed
    1. Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, et al. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Lancet. 2023; 10.1016/S0140-6736(23)02032-9. 10.1016/S0140-6736(23)02032-9 - DOI - PubMed
    1. Jovin T, Costalat V, Lapergue B, Labreuche J, Arquizan C, LASTE-Investigators. IN EXTREMIS LASTE: evaluation of mechanical thrombectomy in large stroke (ASPECTS 0–5) with T or M1 occlusion 〈 7 hours LSW [conference presentation. SVIN Anual Meeting. 2023.

LinkOut - more resources